Skip to content

EBITDA margin at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
22.1%+0.3pp
TFX
TeleflexTFX
13.6%-10.6pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
20.9%-7.3pp
IAR
Integra LifeSciencesIART
-19.5%-30.1pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
20.2%+0.9pp
PDE
Pro-Dex, Inc.PDEX
16.2%-3.9pp

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

Based on trailing twelve months.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's EBITDA margin?
Utah Medical Products (UTMD) reported EBITDA margin of 36.6% in Q1 2026.
How has Utah Medical Products's EBITDA margin changed year-over-year?
Utah Medical Products's EBITDA margin decreased by 8.5% year-over-year, from 40% to 36.6%.
What is the long-term trend for Utah Medical Products's EBITDA margin?
Over 5 years (2020 to 2025), Utah Medical Products's EBITDA margin has grown at a -5.5% compound annual growth rate (CAGR), from 49.5% to 37.3%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.